mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.05 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.05 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.06 |
mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
0.073 |
0.06 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.06 |
mRNA |
KU 0060648 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.06 |
mRNA |
CIL55A |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.07 |
mRNA |
skepinone-L |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.07 |
mRNA |
StemRegenin 1 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.07 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.08 |